Ontology highlight
ABSTRACT: Background
Most cancers maintain telomeres by activating telomerase but a significant minority, mainly of mesenchymal origin, utilize an alternative lengthening of telomeres (ALT) mechanism.Methods
In this study we comparatively analyzed the prognostic relevance of ALT in a monoinstitutional series of 85 liposarcoma patients as a function of the marker (ALT-associated promyelocytic leukemia bodies (APB) versus heterogeneous telomeres) used to classify the tumor.Results
Independently of the detection approach, ALT proved to be a prognostic discriminant of increased mortality, although the prognostic relevance of the two markers appeared at different follow-up intervals (at 10 years for APB and 15 years for telomeres).Conclusions
Overall, we confirmed ALT as a
SUBMITTER: Venturini L
PROVIDER: S-EPMC2894794 | biostudies-literature | 2010 Jun
REPOSITORIES: biostudies-literature